
The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis
2007; Elsevier BV; Volume: 25; Issue: 33 Linguagem: Inglês
10.1016/j.vaccine.2007.05.053
ISSN1873-2518
AutoresÉverton F. Silva, Marco Alberto Medeiros, Alan J. A. McBride, Jim Matsunaga, Gabriela dos Santos Esteves, João Gabriel Rosa Ramos, Cleiton Silva Santos, Júlio Croda, Akira Homma, Odir Antônio Dellagostin, David A. Haake, Mitermayer Galvão dos Reis, Albert I. Ko,
Tópico(s)Viral Infections and Vectors
ResumoSubunit vaccines are a potential intervention strategy against leptospirosis, which is a major public health problem in developing countries and a veterinary disease in livestock and companion animals worldwide. Leptospiral immunoglobulin-like (Lig) proteins are a family of surface-exposed determinants that have Ig-like repeat domains found in virulence factors such as intimin and invasin. We expressed fragments of the repeat domain regions of LigA and LigB from Leptospira interrogans serovar Copenhageni. Immunization of Golden Syrian hamsters with Lig fragments in Freund's adjuvant induced robust antibody responses against recombinant protein and native protein, as detected by ELISA and immunoblot, respectively. A single fragment, LigANI, which corresponds to the six carboxy-terminal Ig-like repeat domains of the LigA molecule, conferred immunoprotection against mortality (67–100%, P < 0.05) in hamsters which received a lethal inoculum of L. interrogans serovar Copenhageni. However, immunization with this fragment did not confer sterilizing immunity. These findings indicate that the carboxy-terminal portion of LigA is an immunoprotective domain and may serve as a vaccine candidate for human and veterinary leptospirosis.
Referência(s)